Haemonetics Corp. (HAE)
105.30
-0.70
(-0.66%)
USD |
NYSE |
Sep 25, 16:00
105.40
+0.10
(+0.09%)
After-Hours: 19:59
Haemonetics Market Cap : 4.788B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 4.788B |
| September 24, 2026 | 4.820B |
| September 23, 2026 | 4.857B |
| September 22, 2026 | 4.935B |
| September 21, 2026 | 4.944B |
| September 18, 2026 | 4.929B |
| September 17, 2026 | 4.893B |
| September 16, 2026 | 4.831B |
| September 15, 2026 | 4.829B |
| September 14, 2026 | 4.834B |
| September 11, 2026 | 4.669B |
| September 10, 2026 | 4.595B |
| September 09, 2026 | 4.691B |
| September 08, 2026 | 4.676B |
| September 04, 2026 | 4.680B |
| September 03, 2026 | 4.677B |
| September 02, 2026 | 4.680B |
| September 01, 2026 | 4.636B |
| August 31, 2026 | 4.687B |
| August 28, 2026 | 4.727B |
| August 27, 2026 | 4.774B |
| August 26, 2026 | 4.847B |
| August 25, 2026 | 4.925B |
| August 24, 2026 | 4.929B |
| August 21, 2026 | 4.947B |
| Date | Value |
|---|---|
| August 20, 2026 | 4.921B |
| August 19, 2026 | 4.930B |
| August 18, 2026 | 4.759B |
| August 17, 2026 | 4.105B |
| August 14, 2026 | 4.129B |
| August 13, 2026 | 4.110B |
| August 12, 2026 | 4.153B |
| August 11, 2026 | 3.966B |
| August 10, 2026 | 3.938B |
| August 07, 2026 | 3.994B |
| August 06, 2026 | 3.866B |
| August 05, 2026 | 3.801B |
| August 04, 2026 | 3.882B |
| August 03, 2026 | 3.927B |
| July 31, 2026 | 3.871B |
| July 30, 2026 | 3.838B |
| July 29, 2026 | 3.865B |
| July 28, 2026 | 3.735B |
| July 27, 2026 | 3.616B |
| July 24, 2026 | 3.565B |
| July 23, 2026 | 3.503B |
| July 22, 2026 | 3.531B |
| July 21, 2026 | 3.533B |
| July 20, 2026 | 3.537B |
| July 17, 2026 | 3.523B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Globus Medical, Inc. | 10.00B |
| Abbott Laboratories | 175.27B |
| AngioDynamics, Inc. | 645.94M |
| Alphatec Holdings, Inc. | 1.545B |
| AtriCure, Inc. | 2.969B |
Market Cap Related Metrics
| PE Ratio | 51.36 |
| PS Ratio | 3.633 |
| Price to Book Value | 5.720 |
| Price to Free Cash Flow | 16.87 |
| Price | 105.30 |
| Earnings Yield | 1.95% |
| Operating PE Ratio | 19.78 |
| Normalized PE Ratio | 31.51 |